Assessment of the kidneys: Magnetic resonance angiography, perfusion and diffusion

Journal of Cardiovascular Magnetic Resonance

Volumn 13, Issue 1, 2011, Pages

  Attenberger, Ulrike I ^a   Morelli, John N ^b   Schoenberg, Stefan O ^a   Michaely, Henrik J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENIC ACID; GADODIAMIDE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

AORTA ARCH; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FLUOROSCOPY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY EXAMINATION; KIDNEY FIBROSIS; KIDNEY PERFUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MULTICENTER STUDY (TOPIC); NEPHROGENIC SYSTEMIC FIBROSIS; NONHUMAN; PATIENT DECISION MAKING; PRIORITY JOURNAL; RENAL ARTERY; RENOVASCULAR HYPERTENSION; REVIEW; SINGLE DRUG DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VOXEL BASED MORPHOMETRY; ARTICLE; KIDNEY; KIDNEY CIRCULATION; METHODOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; RISK ASSESSMENT; SCINTIGRAPHY; VASCULARIZATION;

CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; KIDNEY; MAGNETIC RESONANCE ANGIOGRAPHY; PATIENT SELECTION; PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RENAL CIRCULATION; RISK ASSESSMENT;

EID: 84857681845     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-13-70     Document Type: Review

References (71)

1. Body MR angiography with gadolinium contrast agents. Prince MR, Magn Reson Imaging Clin N Am 1996 4 11 24 8673710 (Pubitemid 26091978)
2. Renal MR angiography: a comprehensive approach. Prince MR, J Magn Reson Imaging 1998 8 511 516 10.1002/jmri.1880080302 9626863 (Pubitemid 28267768)
3. Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection of contrast material arrival in the aorta. Prince MR, Chenevert TL, Foo TK, Londy FJ, Ward JS, Maki JH, Radiology 1997 203 109 114 9122376 (Pubitemid 27142716)
4. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Schoenberg SO, Rieger J, Weber CH, Michaely HJ, Waggershauser T, Ittrich C, Dietrich O, Reiser MF, Radiology 2005 235 687 698 10.1148/radiol.2352031693 15770035 (Pubitemid 40571115)
5. Time-resolved contrast-enhanced 3D MR angiography. Korosec FR, Frayne R, Grist TM, Mistretta CA, Magn Reson Med 1996 36 345 351 10.1002/mrm.1910360304 8875403 (Pubitemid 26299259)
6. Abdominal and pelvic MR angiography. Michaely HJ, Attenberger UI, Kramer H, Nael K, Reiser MF, Schoenberg SO, Magn Reson Imaging Clin N Am 2007 15 301 314 v-vi 10.1016/j.mric.2007.06.001 17893051 (Pubitemid 47429998)
7. SENSE: sensitivity encoding for fast MRI. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P, Magn Reson Med 1999 42 952 962 10.1002/(SICI)1522- 2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S 10542355 (Pubitemid 29521486)
8. Generalized Autocalibrating Partially Parallel Acquisitions (GRAPPA). Griswold M, Jakob P, Heidemann R, Nittka M, Jellus V, Wang J, Kiefer B, Haase A, Magn Reson Med 2002 47 1202 1210 10.1002/mrm.10171 12111967 (Pubitemid 34587412)
9. High-resolution renal MRA: comparison of image quality and vessel depiction with different parallel imaging acceleration factors. Michaely HJ, Herrmann KA, Kramer H, Dietrich O, Laub G, Reiser MF, Schoenberg SO, J Magn Reson Imaging 2006 24 95 100 10.1002/jmri.20595 16729261
10. Sensitivity encoding (SENSE) for contrast-enhanced 3D MR angiography of the abdominal arteries. Born M, Willinek WA, Gieseke J, von Falkenhausen M, Schild H, Kuhl CK, J Magn Reson Imaging 2005 22 559 565 10.1002/jmri.20425 16161084 (Pubitemid 41416416)
11. Direct comparison of sensitivity encoding (SENSE) accelerated and conventional 3D contrast enhanced magnetic resonance angiography (CE-MRA) of renal arteries: effect of increasing spatial resolution. Muthupillai R, Douglas E, Huber S, Lambert B, Pereyra M, Wilson GJ, Flamm SD, J Magn Reson Imaging 2010 31 149 159 10.1002/jmri.22002 20027583
12. Renal Magnetic Resonance Angiography at 3.0 Tesla Using a 32-Element Phased-Array Coil System and Parallel Imaging in 2 Directions. Fenchel M, Nael K, Deshpande VS, Finn JP, Kramer U, Miller S, Ruehm S, Laub G, Invest Radiol 2006 41 697 703 10.1097/01.rli.0000233319.04760.a4 16896305 (Pubitemid 44213748)
13. Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA. Vasbinder GBC, Maki JH, Nijenhuis RJ, Leiner T, Wilson GJ, Kessels AG, Lemarie EE, Kaandorp DW, Ho KY, van Engelshoven JM, J Magn Reson Imaging 2002 16 685 696 10.1002/jmri.10214 12451582 (Pubitemid 35375567)
14. Intraindividual comparison of high-spatial-resolution abdominal MR angiography at 1.5 T and 3.0 T: initial experience. Michaely HJ, Kramer H, Dietrich O, Nael K, Lodemann KP, Reiser MF, Schoenberg SO, Radiology 2007 244 907 913 10.1148/radiol.2443061647 17709837 (Pubitemid 47292104)
15. High-Resolution Magnetic Resonance Angiography of the Renal Arteries Using Parallel Imaging Acquisition Techniques at 3.0 T: Initial Experience. Kramer U, Nael K, Laub G, Nyborg GK, Fenchel M, Miller S, Claussen CD, Finn JP, Invest Radiol 2006 41 125 132 10.1097/01.rli.0000195838.94440.20 16428983 (Pubitemid 44406209)
16. Isotropic high-spatial-resolution contrast-enhanced 3.0-T MR angiography in patients suspected of having renal artery stenosis. Kramer U, Wiskirchen J, Fenchel MC, Seeger A, Laub G, Tepe G, Finn JP, Claussen CD, Miller S, Radiology 2008 247 228 240 10.1148/radiol.2471070565 18270376
17. The feasibility of spatial high-resolution magnetic resonance angiography (MRA) of the renal arteries at 3.0 T. Michaely HJ, Nael K, Schoenberg SO, Finn JP, Laub G, Reiser MF, Ruehm SG, Rofo 2005 177 800 804 10.1055/s-2005-858175 15902628 (Pubitemid 40873822)
18. Comparison of gadodiamide-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of renal artery stenosis: results of a phase III multicenter trial. Garovic VD, Achauer MA, Kittner T, Horak D, Sheng R, Stanson AW, J Magn Reson Imaging 2010 31 390 397 10.1002/jmri.22032 20099352
19. A multicenter, site-independent, blinded study to compare the diagnostic accuracy of contrast-enhanced magnetic resonance angiography using 1.0 M gadobutrol (Gadovist) to intraarterial digital subtraction angiography in body arteries. Schaefer FK, Schaefer PJ, Altjohann C, Bourne M, Decobelli F, Goyen M, Griffiths PD, Kopka L, Kreitner KF, Link J, et al. Eur J Radiol 2007 61 315 323 10.1016/j.ejrad.2006.09.002 17074459 (Pubitemid 46116786)
20. The impact of the dosage of intravenous gadolinium-chelates on the vascular signal intensity in MR angiography. Heverhagen JT, Reitz I, Pavlicova M, Levine AL, Klose KJ, Wagner HJ, Eur Radiol 2007 17 626 637 10.1007/s00330-006-0419-7 17013594
21. Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA. Heverhagen JT, Wright CL, Schmalbrock P, Knopp MV, Eur Radiol 2008
22. Gadobenate dimeglumine-enhanced MR angiography: Diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography. Schneider G, Ballarati C, Grazioli L, Manfredi R, Thurnher S, Kroencke TJ, Taupitz M, Merlino B, Bonomo L, Shen N, et al. J Magn Reson Imaging 2007 26 1020 1032 10.1002/jmri.21127 17896354 (Pubitemid 47548164)
23. Incidence of nephrogenic systemic fibrosis at two large medical centers. Prince MR, Zhang H, Morris M, MacGregor JL, Grossman ME, Silberzweig J, DeLapaz RL, Lee HJ, Magro CM, Valeri AM, Radiology 2008 248 807 816 10.1148/radiol. 2483071863 18710976
24. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ, Invest Radiol 2008 43 817 828 10.1097/RLI.0b013e3181852171 19002053
25. European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents. http://www.ema.europa.eu/pdfs/human/press/pr/73981809en.pdf
26. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate. Hadizadeh DR, Von Falkenhausen M, Kukuk GM, Schoneseiffen K, Gieseke J, Schild HH, Willinek WA, AJR Am J Roentgenol 2010 194 821 829 10.2214/AJR.09.3306 20173166
27. 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. Goyen M, Lauenstein T, Herborn C, Debatin J, Bosk S, Ruehm S, J Magn Reson Imaging 2001 14 602 607 10.1002/jmri.1225 11747013 (Pubitemid 33029547)
28. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography. Herborn CU, Lauenstein TC, Ruehm SG, Bosk S, Debatin JF, Goyen M, Invest Radiol 2003 38 27 33 10.1097/00004424-200301000-00004 12496518 (Pubitemid 36083433)
29. MR angiography of the renal arteries: intraindividual comparison of double-dose contrast enhancement at 1.5 T with standard dose at 3 T. Herborn CU, Runge VM, Watkins DM, Gendron JM, Naul LG, AJR Am J Roentgenol 2008 190 173 177 10.2214/AJR.07.2486 18094308
30. Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T. Attenberger UI, Michaely HJ, Wintersperger BJ, Sourbron SP, Lodemann KP, Reiser MF, Schoenberg SO, Eur Radiol 2008 18 1260 1268 10.1007/s00330-008-0873-5 18278504
31. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T. Voth M, Haneder S, Huck K, Gutfleisch A, Schonberg SO, Michaely HJ, Invest Radiol 2009 44 627 633 10.1097/RLI.0b013e3181b4c26c 19652610
32. Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla. Voth M, Michaely HJ, Schwenke C, Vos B, Pietsch H, Eur Radiol 2010
33. Steady-state free precession MRA of the renal arteries: breath-hold and navigator-gated techniques vs. CE-MRA. Maki JH, Wilson GJ, Eubank WB, Glickerman DJ, Pipavath S, Hoogeveen RM, J Magn Reson Imaging 2007 26 966 973 10.1002/jmri.21134 17896351 (Pubitemid 47548158)
34. Navigator-gated MR angiography of the renal arteries: a potential screening tool for renal artery stenosis. Maki JH, Wilson GJ, Eubank WB, Glickerman DJ, Millan JA, Hoogeveen RM, AJR Am J Roentgenol 2007 188 540 546 10.2214/AJR.06.1138 17515344
35. Free-breathing renal magnetic resonance angiography with steady-state free-precession and slab-selective spin inversion combined with radial k-space sampling and water-selective excitation. Katoh M, Spuentrup E, Stuber M, Hoogeveen RM, Gunther RW, Buecker A, Magn Reson Med 2005 53 1228 1233 10.1002/mrm.20467 15844141 (Pubitemid 40627805)
36. Free-breathing renal MR angiography with steady-state free-precession (SSFP) and slab-selective spin inversion: initial results. Katoh M, Buecker A, Stuber M, Gunther RW, Spuentrup E, Kidney Int 2004 66 1272 1278 10.1111/j.1523-1755.2004.00882.x 15327427 (Pubitemid 39121038)
37. Improved arterial visibility using short-tau inversion-recovery (STIR) fat suppression in non-contrast-enhanced time-spatial labeling inversion pulse (Time-SLIP) renal MR angiography (MRA). Shonai T, Takahashi T, Ikeguchi H, Miyazaki M, Amano K, Yui M, J Magn Reson Imaging 2009 29 1471 1477 10.1002/jmri.21792 19472424
38. ECG-gated nonenhanced 3D steady-state free precession MR angiography in assessment of transplant renal arteries: comparison with DSA. Lanzman RS, Voiculescu A, Walther C, Ringelstein A, Bi X, Schmitt P, Freitag SM, Won S, Scherer A, Blondin D, Radiology 2009 252 914 921 10.1148/radiol.2531082260 19635833
39. Renal transplant: nonenhanced renal MR angiography with magnetization-prepared steady-state free precession. Liu X, Berg N, Sheehan J, Bi X, Weale P, Jerecic R, Carr J, Radiology 2009 251 535 542 10.1148/radiol.2512081094 19261926
40. Diagnosis and treatment of renovascular hypertension: a cost-benefit analysis. Bolduc JP, Oliva VL, Therasse E, Giroux MF, Bouchard L, Perreault P, Cliche A, Soulez G, AJR Am J Roentgenol 2005 184 931 937 15728620 (Pubitemid 43899524)
41. Three-dimensional MR angiography of the renal arteries in a single breath-hold. Hany T, Debatin J, Schmidt M, McKinnon G, Krestin G, Pfammatter T, Radiology 1996 201 218
42. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Prince M, Narasimham D, Stanley J, et al. Radiology 1995 197 785 792 7480757
43. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, Maki JH, Leiner T, Beek FJ, Korst MB, Flobbe K, de Haan MW, et al. Ann Intern Med 2004 141 674 682 15520423 (Pubitemid 39434840)
44. Revascularization versus medical therapy for renal-artery stenosis. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, et al. N Engl J Med 2009 361 1953 1962 19907042
45. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. Bax L, Mali WP, Buskens E, Koomans HA, Beutler JJ, Braam B, Beek FJ, Rabelink TJ, Postma CT, Huysmans FT, et al. J Nephrol 2003 16 807 812 14736007 (Pubitemid 38714223)
46. MRI-measurement of perfusion and glomerular filtration in the human kidney with a separable compartment model. Sourbron SP, Michaely HJ, Reiser MF, Schoenberg SO, Invest Radiol 2008 43 40 48 10.1097/RLI.0b013e31815597c5 18097276
47. Renal artery stenosis: functional assessment with dynamic MR perfusion measurements - feasibility study. Michaely HJ, Schoenberg SO, Oesingmann N, Ittrich C, Buhlig C, Friedrich D, Struwe A, Rieger J, Reininger C, Samtleben W, et al. Radiology 2006 238 586 596 10.1148/radiol.2382041553 16436819 (Pubitemid 43134371)
48. Quantitative Assessment of Glomerular Filtration Rate with MR Gadolinium Slope Clearance Measurements: A Phase I Trial. Boss A, Martirosian P, Gehrmann M, Artunc F, Risler T, Oesingmann N, Claussen CD, Schick F, Kuper K, Schlemmer HP, Radiology 2007 242 783 790 10.1148/radiol.2423060209 17209166
49. Comprehensive assessment of renal function and vessel morphology in potential living kidney donors: an MRI-based approach. Rossi C, Boss A, Artunc F, Yildiz S, Martirosian P, Dittmann H, Claussen CD, Heyne N, Schick F, Schlemmer HP, Invest Radiol 2009 44 705 711 10.1097/RLI.0b013e3181b35a70 19809340
50. Diffusion tensor imaging of the kidney with parallel imaging: initial clinical experience. Notohamiprodjo M, Glaser C, Herrmann KA, Dietrich O, Attenberger UI, Reiser MF, Schoenberg SO, Michaely HJ, Invest Radiol 2008 43 677 685 10.1097/RLI.0b013e31817d14e6 18791409
51. Diffusion-weighted MR imaging of kidneys in patients with chronic kidney disease: initial study. Xu X, Fang W, Ling H, Chai W, Chen K, Eur Radiol 2010 20 978 983 10.1007/s00330-009-1619-8 19789876
52. Diffusion tensor imaging of renal ischemia reperfusion injury in an experimental model. Cheung JS, Fan SJ, Chow AM, Zhang J, Man K, Wu EX, NMR Biomed 2010 23 496 502 10.1002/nbm.1486 20175152
53. [Functional MRI of transplanted kidneys using diffusion-weighted imaging]. Blondin D, Lanzman RS, Mathys C, Grotemeyer D, Voiculescu A, Sandmann W, Rump LC, Modder U, Wittsack HJ, Rofo 2009 181 1162 1167 10.1055/s-0028- 1109511 19582653
54. T2' Imaging of Native Kidneys and Renal Allografts-a Feasibility Study. Mathys C, Blondin D, Wittsack HJ, Miese FR, Rybacki K, Walther C, Holstein A, Lanzman RS, Rofo 2010
55. Blood oxygen level-dependent and perfusion magnetic resonance imaging: detecting differences in oxygen bioavailability and blood flow in transplanted kidneys. Sadowski EA, Djamali A, Wentland AL, Muehrer R, Becker BN, Grist TM, Fain SB, Magn Reson Imaging 2010 28 56 64 10.1016/j.mri.2009.05.044 19577402
56. Evolution of renal oxygen content measured by BOLD MRI downstream a chronic renal artery stenosis. Rognant N, Guebre-Egziabher F, Bacchetta J, Janier M, Hiba B, Langlois JB, Gadet R, Laville M, Juillard L, Nephrol Dial Transplant 2010
57. The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Han F, Xiao W, Xu Y, Wu J, Wang Q, Wang H, Zhang M, Chen J, Nephrol Dial Transplant 2008 23 2666 2672 10.1093/ndt/gfn064 18308769
58. Comprehensive MR evaluation of renal disease: added clinical value of quantified renal perfusion values over single MR angiography. Attenberger UI, Sourbron SP, Schoenberg SO, Morelli J, Leiner T, Schoeppler GM, Samtleben W, Birkemeier KL, Glaser C, Reiser MF, Michaely HJ, J Magn Reson Imaging 2010 31 125 133 10.1002/jmri.21994 20027580
59. Assessment of chronic renal allograft nephropathy using contrast-enhanced MRI: a pilot study. Pereira RS, McLaughlin K, Yilmaz S, Mahallati H, AJR Am J Roentgenol 2010 194 407 413 10.2214/AJR.09.2912 20410386
60. Diffusion-weighted MR imaging of kidneys in renal artery stenosis. Yildirim E, Kirbas I, Teksam M, Karadeli E, Gullu H, Ozer I, Eur J Radiol 2008 65 148 153 10.1016/j.ejrad.2007.03.007 17537606
61. Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Togao O, Doi S, Kuro-o M, Masaki T, Yorioka N, Takahashi M, Radiology 2010 255 772 780 10.1148/radiol.10091735 20406881
62. Diffusion tensor MRI of the kidney at 3.0 and 1.5 Tesla. Kido A, Kataoka M, Yamamoto A, Nakamoto Y, Umeoka S, Koyama T, Maetani Y, Isoda H, Tamai K, Morisawa N, et al. Acta Radiol 2010
63. Intraindividual comparison of MR-renal perfusion imaging at 1.5 T and 3.0 T. Michaely HJ, Kramer H, Oesingmann N, Lodemann KP, Miserock K, Reiser MF, Schoenberg SO, Invest Radiol 2007 42 406 411 10.1097/01.rli.0000262561.47892.b8 17507812 (Pubitemid 46788740)
64. Evaluation of intrarenal oxygenation by BOLD MRI at 3.0 T. Li LP, Vu AT, Li BS, Dunkle E, Prasad PV, J Magn Reson Imaging 2004 20 901 904 10.1002/jmri.20176 15503343 (Pubitemid 39426089)
65. Renal perfusion in humans: MR imaging with spin tagging of arterial water. Roberts DA, Detre JA, Bolinger L, Insko EK, Lenkinski RE, Pentecost MJ, Leigh JS Jr, Radiology 1995 196 281 286 7784582
66. FAIR true-FISP perfusion imaging of the kidneys. Martirosian P, Klose U, Mader I, Schick F, Magn Reson Med 2004 51 353 361 10.1002/mrm.10709 14755661 (Pubitemid 38168595)
67. Renal disease: value of functional magnetic resonance imaging with flow and perfusion measurements. Michaely HJ, Schoenberg SO, Ittrich C, Dikow R, Bock M, Guenther M, Invest Radiol 2004 39 698 705 10.1097/00004424-200411000-00008 15486531 (Pubitemid 39425963)
68. Perfusion MR Imaging with FAIR True FISP Spin Labeling in Patients with and without Renal Artery Stenosis: Initial Experience. Fenchel M, Martirosian P, Langanke J, Giersch J, Miller S, Stauder NI, Kramer U, Claussen CD, Schick F, Radiology 2006
69. Multidirectional flow analysis by cardiovascular magnetic resonance in aneurysm development following repair of aortic coarctation. Frydrychowicz A, Arnold R, Hirtler D, Schlensak C, Stalder AF, Hennig J, Langer M, Markl M, J Cardiovasc Magn Reson 2008 10 30 10.1186/1532-429X-10-30 18538035
70. Three-dimensional flow characteristics in aortic coarctation and poststenotic dilatation. Markl M, Arnold R, Hirtler D, von Zur Muhlen C, Harloff A, Langer M, Hennig J, Frydrychowicz A, J Comput Assist Tomogr 2009 33 776 778 10.1097/RCT.0b013e3181906766 19820510
71. Retrograde embolism from the descending aorta: visualization by multidirectional 3D velocity mapping in cryptogenic stroke. Harloff A, Strecker C, Dudler P, Nussbaumer A, Frydrychowicz A, Olschewski M, Bock J, Stalder AF, Stroh AL, Weiller C, et al. Stroke 2009 40 1505 1508 10.1161/STROKEAHA.108. 530030 19182085